andrew huberman retatrutide on Retatrutide: What He Said and What the Data Shows The Next Ozempic Isn't Just
Description
The science of sustainable fat loss and GLP-1 therapy
The US Food and Drug Administration allowed some pharmacies to compound or custom-mix versions of two GLP-1 medications, semaglutide and tirzepatide, after those drugs went into shortage in 2022
Retatrutide may reduce alcohol interest for some people, but it should not be used on its own to manage alcohol cravings or heavy drinking
Diabetologia 62 , 665675 (2019)
[95] reported wound healing complications in two patients undergoing breast surgery while receiving GLP-1 RAs
Recent studies have linked obesity to an increased risk of TNBC and malignancies
